In Vitro Toxicity Testing: Technologies and Global Markets

Published - Feb 2019| Code - PHM017F| Publisher - BCC Publishing

Report Highlights

The global market for in vitro toxicity testing should grow from $7.4 billion in 2018 to reach $10.4 billion by 2023 at a compound annual growth rate (CAGR) of 7.1% for the period of 2018-2023.

Report Includes

  • 52 data table and 18 additional tables
  • An overview of the global markets and technologies for the in vitro toxicity testing techniques within the pharmaceutical industry
  • Analyses of global market trends with data from 2017, 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Information on latest trends, technological developments and government regulations that influence the growth of the market
  • A breakdown of influential factors, such as validation of the alternative measures for toxicity and toxicity testing strategies for chemicals, pesticides, and food additives
  • Evaluation covering equipment, assays, cells, reagents, and services used in toxicity testing
  • Profiles of major players in the toxicology market, including Abbott Laboratories, Inc., Agilent Technologies, Inc., Evotec AG, GE Healthcare Life Sciences and Thermo Fisher Scientific, Inc.

Report Scope

The scope of the report encompasses the major types of traditional toxicity testing that have been used, and the in vitro techniques that are being developed by industry, government agencies and nonprofits. It analyzes current market status, examines drivers on future markets and presents forecasts of growth over the next five years. 

Technology developments, including the latest trends, are discussed. Other influential factors such as validation and testing strategies for pharmaceuticals, cosmetics, and chemicals also have been included. 

Regulatory drivers play a large role in toxicology, determining the specific parameters of tests that have been explicitly required. They also heavily influence the testing that is performed by companies in earlier stages of research. The report examines the regulatory role and the different federal and international agencies that play an active role in in vitro toxicology research, development and adoption.

Analyst Credentials

ANUJ PATHAK has written and researched the global medical device market, surgical instruments and biotechnology market. Skilled in information technology and computer management, he has an undergraduate business degree and an MBA degree.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
Title/Chapter Name Pages Price Member Price
Full Report: In Vitro Toxicity Testing: Technologies and Global Markets 174 $5,500 Free
Chapter- 1: Introduction7Free DownloadFree
Chapter- 2: Summary and Highlights4$250Free
Chapter- 3: Market and Technology Background15$474Free
Chapter- 4: Market Breakdown by Toxicity Endpoints and Tests22$695Free
Chapter- 5: Market Breakdown by End-User Industry14$443Free
Chapter- 6: Market Breakdown by Tool/Technology15$474Free
Chapter- 7: Market Breakdown by Component12$379Free
Chapter- 8: Market Breakdown by Region38$1,201Free
Chapter- 9: Patent Review/ New Developments16$506Free
Chapter- 10: Company Profiles31$980Free
Published - Jan-2014| Analyst - Robert Hunter| Code - PHM017E

Report Highlights

The global in vitro toxicity testing market was valued at $4 billion in 2011 and more than $4.9 billion in 2012. This market is estimated to reach nearly $9.9 billion in 2017, with a compound annual growth rate (CAGR) of 14.7% for the five-year period, 2012 to 2017.

Report Includes

  • An overview of the global in vitro toxicity testing market, with assessments of its growth potential over the next five years and the current market scenario for alternative measures to animal testing.
  • Analyses of market trends, with data from 2011 and 2012, and projections of CAGRs for the period 2012 and 2017.
  • Discussion of the two major technology-based approaches, mechanistic and nonmechanistic.
  • A breakdown of influential factors, such as validation of the alternative measures for toxicity and toxicity testing strategies for chemicals, pesticides, and food additives.
  • Profiles of major players in the industry

Published - Sep-2010| Analyst - Paul Evers| Code - PHM017D

Report Highlights

  • The global in vitro toxicity (predictive toxicity) testing market is valued at more than $1.3 billion in 2010.  With heightened awareness of animal welfare in laboratory research testing, the in vitro toxicity testing market has an anticipated value of $2.7 billion in 2015, a compound annual growth rate (CAGR) of 15% between 2010 and 2015.
  • The largest market sector is currently the cosmetics and personal-care industry, which accounts for a market share of more than 50%. This sector is currently valued at $702 million and is expected to reach $1.3 billion by 2015, a compound annual growth rate (CAGR) of 13.1%.
  • The pharmaceuticals segment is one of the most significant with a 32% market share valued at $424 million in 2010. By 2015, this sector is projected to reach a value of $976 million, a compound annual growth rate (CAGR) of 18.2%.
Published - Mar-2007| Analyst - Vanita Khetan| Code - PHM017C

Report Highlights

  • The U.S. in vitro toxicity (predictive toxicity) testing market has been valued at $765 million in 2006. At a compound annual growth rate (CAGR) of 14.4%, the total U.S. market will grow to reach $1.5 billion by 2011.
  • Mechanistic toxicology testing had the highest growth through the forecast period, with an estimated CAGR of 21.8%. This sector of the market will be worth $720 million by 2011.
  • Non-mechanistic toxicology testing was the larger of the two sectors in 2006. Even with a CAGR of 9.4%, it will still maintain the majority of the market at $780 million in 2011.
Published - Jun-2003| Analyst - Sam Brauer| Code - PHM017B

Report Highlights

  • The pharmaceutical industry accounts for more than 90% of the industry.
  • In vitro toxicology growth (12.4%/year) will be higher than pharmaceutical R& D.
  • The pharmaceutical market will reach about $18.58 billion by 2007.
  • All other markets will grow 8%/year to reach $103 milion.
  • Overall, in vitro toxicology markets will see an AAGR of 12.1%.

RELATED REPORTS
Share This Report